Koshinski Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.73M | Buy |
3,447
+947
| +38% | +$455K | 0.09% | 199 |
|
|
2026
Q1 | $1.23M | Sell |
2,500
-351
| -12% | -$190K | 0.08% | 244 |
|
|
2025
Q4 | $1.65M | Sell |
2,851
-331
| -10% | -$187K | 0.11% | 178 |
|
|
2025
Q3 | $1.54M | Sell |
3,182
-54
| -2% | -$25.1K | 0.1% | 189 |
|
|
2025
Q2 | $1.31M | Buy |
3,236
+96
| +3% | +$40.1K | 0.1% | 205 |
|
|
2025
Q1 | $1.56M | Buy |
3,140
+440
| +16% | +$238K | 0.13% | 163 |
|
|
2024
Q4 | $1.4B | Buy |
2,700
+54
| +2% | +$29.7K | 0.12% | 166 |
|
|
2024
Q3 | $1.64M | Sell |
2,646
-1,631
| -38% | -$965K | 0.14% | 144 |
|
|
2024
Q2 | $2.27M | Buy |
4,277
+62
| +1% | +$35.5K | 0.21% | 102 |
|
|
2024
Q1 | $2.45M | Buy |
4,215
+1,108
| +36% | +$622K | 0.25% | 87 |
|
|
2023
Q4 | $1.65M | Sell |
3,107
-2,207
| -42% | -$1.07M | 0.25% | 108 |
|
|
2023
Q3 | $2.69M | Sell |
5,314
-29
| -0.5% | -$15.5K | 0.31% | 72 |
|
|
2023
Q2 | $2.79M | Sell |
5,343
-2,121
| -28% | -$1.14M | 0.3% | 76 |
|
|
2023
Q1 | $4.3M | Buy |
7,464
+230
| +3% | +$130K | 0.42% | 53 |
|
|
2022
Q4 | $3.98M | Buy |
7,234
+86
| +1% | +$45.6K | 0.39% | 58 |
|
|
2022
Q3 | $3.63M | Buy |
7,148
+251
| +4% | +$140K | 0.43% | 55 |
|
|
2022
Q2 | $3.75M | Sell |
6,897
-31
| -0.4% | -$17.1K | 0.37% | 64 |
|
|
2022
Q1 | $4.09M | Buy |
6,928
+58
| +0.8% | +$33.3K | 0.34% | 68 |
|
|
2021
Q4 | $4.58M | Buy |
6,870
+54
| +0.8% | +$33.7K | 0.37% | 54 |
|
|
2021
Q3 | $3.89M | Buy |
6,816
+2,067
| +44% | +$1.13M | 0.34% | 62 |
|
|
2021
Q2 | $2.4M | Sell |
4,749
-2,041
| -30% | -$963K | 0.3% | 83 |
|
|
2021
Q1 | $3.1M | Buy |
6,790
+39
| +0.6% | +$18.6K | 0.33% | 77 |
|
|
2020
Q4 | $3.15M | Buy |
6,751
+1,277
| +23% | +$599K | 0.4% | 58 |
|
|
2020
Q3 | $2.56K | Buy |
5,474
+175
| +3% | +$72.3K | 0.34% | 70 |
|
|
2020
Q2 | $1.92M | Buy |
5,299
+28
| +0.5% | +$9.38K | 0.31% | 83 |
|
|
2020
Q1 | $1.5M | Sell |
5,271
-14
| -0.3% | -$4.42K | 0.31% | 84 |
|
|
2019
Q4 | $1.72M | Buy |
5,285
+508
| +11% | +$154K | 0.3% | 95 |
|
|
2019
Q3 | $1.39M | Sell |
4,777
-1,349
| -22% | -$386K | 0.97% | 31 |
|
|
2019
Q2 | $1.8M | Sell |
6,126
-233
| -4% | -$64.2K | 0.73% | 32 |
|
|
2019
Q1 | $1.74K | Hold |
6,359
| – | – | 0.47% | 52 |
|
|
2018
Q4 | $1.42M | Sell |
6,359
-932
| -13% | -$219K | 0.35% | 81 |
|
|
2018
Q3 | $1.78M | Buy |
7,291
+3,952
| +118% | +$909K | 0.25% | 115 |
|
|
2018
Q2 | $692K | Hold |
3,339
| – | – | 0.21% | 153 |
|
|
2018
Q1 | $689K | Sell |
3,339
-773
| -19% | -$162K | 0.21% | 159 |
|
|
2017
Q4 | $781K | Buy |
4,112
+13
| +0.3% | +$2.49K | 0.2% | 179 |
|
|
2017
Q3 | $776K | Buy |
4,099
+22
| +0.5% | +$3.98K | 0.25% | 129 |
|
|
2017
Q2 | $711K | Buy |
4,077
+1,127
| +38% | +$189K | 0.26% | 126 |
|
|
2017
Q1 | $453K | Sell |
2,950
-43
| -1% | -$6.57K | 0.18% | 173 |
|
|
2016
Q4 | $422K | Sell |
2,993
-106
| -3% | -$15.6K | 0.21% | 155 |
|
|
2016
Q3 | $493K | Buy |
3,099
+113
| +4% | +$17.4K | 0.25% | 136 |
|
|
2016
Q2 | $441K | Buy |
2,986
+230
| +8% | +$33.9K | 0.24% | 138 |
|
|
2016
Q1 | $390K | Buy |
+2,756
| New | +$369K | 0.25% | 131 |
|
Other funds holding TMO
Koshinski Asset Management's TMO Position: Q2 2026 in Review
Koshinski Asset Management increased its Thermo Fisher Scientific (TMO) stake by 38% in Q2 2026, buying an estimated $455K and bringing the position to 3,447 shares worth $1.73M. The position accounts for 0.09% of the portfolio, ranked #199.
Koshinski Asset Management first reported a position in TMO in Q1 2016 and has held it in 42 quarters since. The position peaked at $1.4B in Q4 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Koshinski Asset Management held 3,447 shares of Thermo Fisher Scientific worth $1.73M as of Q2 2026.
- Koshinski Asset Management bought 947 Thermo Fisher Scientific shares in Q2 2026, an estimated $455K.
- Thermo Fisher Scientific made up 0.09% of Koshinski Asset Management's portfolio in Q2 2026, its #199 holding.
- Koshinski Asset Management first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 42 quarters since.
- Koshinski Asset Management's Thermo Fisher Scientific position peaked at $1.4B in Q4 2024.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.